Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acetaminophen-induced
10%
Acute Liver Failure
97%
Allograft
10%
Autoimmune Hepatitis
10%
Bone Disease
10%
Cholestatic Liver Disease
10%
Chronic Hepatitis C
17%
Chronic Hepatitis C Virus Infection
8%
Chronic Liver Disease
11%
Cirrhosis
10%
Clinical Outcomes
11%
Donor Graft
9%
End-stage Liver Disease
8%
Etiology
26%
Failure Studies
9%
Fibrosis
12%
Graft Survival
12%
Hepatitis
14%
Hepatitis B
9%
Hepatitis B Virus
15%
Hepatitis C
25%
Hepatitis C Virus
42%
Hepatocellular Carcinoma
33%
Immune Response
8%
Immunosuppression
15%
Interferon-α (IFN-α)
22%
Liver
16%
Liver Disease
9%
Liver Transplant Recipients
47%
Liver Transplantation
100%
MELD Score
14%
MicroRNA
15%
Multicenter Cohort Study
14%
Orthotopic Liver Transplantation
43%
Patient Survival
18%
Pretransplant
7%
Primary Biliary Cirrhosis
17%
Primary Sclerosing Cholangitis
16%
Prognostic Model
9%
Recurrent Hepatitis
7%
Retransplantation
9%
Ribavirin
19%
Solid Organ Transplantation
11%
Survival Rate
12%
Tauroursodeoxycholic Acid (TUDCA)
9%
Transplant-free Survival
15%
Transplantation
20%
United States
21%
Virus-induced
10%
Virus-specific
9%
Medicine and Dentistry
Acute Liver Failure
42%
Allograft
14%
Alpha-Fetoprotein
6%
Antiviral Therapy
8%
Bilirubin
6%
Biopsy Technique
8%
Bone Density
9%
Bone Disease
11%
Child-Pugh Score
5%
Chronic Graft Rejection
5%
Chronic Liver Disease
7%
Cohort Analysis
14%
Diseases
32%
End Stage Liver Disease
13%
Etiology
19%
Graft Survival
8%
Hepatic Encephalopathy
6%
Hepatitis
9%
Hepatitis B Virus
5%
Hepatitis C
18%
Hepatocellular Carcinoma
36%
Immunosuppressive Treatment
8%
Infection
5%
Intracranial Hypertension
7%
Liver Cirrhosis
15%
Liver Disease
33%
Liver Failure
7%
Liver Graft
33%
Liver Transplantation
98%
Logistic Regression Analysis
5%
Long Term Survival
6%
Lumbar Spine
9%
Model For End Stage Liver Disease Score
7%
Model for End-Stage Liver Disease
7%
Neoplasm
7%
Osteodystrophy
6%
Paracetamol
12%
Pathologist
5%
Primary Biliary Cirrhosis
25%
Primary Sclerosing Cholangitis
17%
Prognostic Model
6%
Quality of Life
6%
Recurrent Disease
9%
Retransplantation
9%
Retrospective Cohort Study
5%
Survival Rate
11%
Transcatheter Arterial Chemoembolization
16%
Ursodeoxycholic Acid
9%
Immunology and Microbiology
Actin
5%
Allograft
19%
Antigen
5%
Autoimmune Hepatitis
8%
Autoimmunity
11%
Blood Level
9%
Blood Plasma
5%
Blood Transfusion
5%
CD4
12%
Cirrhosis
19%
Cytokine
7%
Cytotoxic T-Cell
6%
Drug Megadose
5%
Globulin
9%
Hepatitis
24%
Hepatitis B
17%
Hepatitis B Virus
20%
Hepatitis C
58%
Hepatitis C Virus
57%
Hepatitis Virus
5%
Human Immunodeficiency Virus
7%
Immune Response
16%
Immunosuppression
8%
Immunosuppressive Drug
7%
Infection
29%
Infectious Disease
28%
Inflammation
7%
Innate Immune System
5%
interferon
30%
Interleukin 10
5%
Interleukin 17
7%
Liver Transplantation
69%
Primary Sclerosing Cholangitis
9%
Ribavirin
8%
Ribonucleic Acid
12%
Signal Transduction
5%
Solid Organ Transplantation
9%
Steroid
5%
T Cell
7%
Transplant Rejection
5%
Viral Clearance
6%
Viral Load
6%
Virus
5%